Original ResearchClinical Outcome of Isolated Tricuspid Regurgitation
Under an Elsevier user license
open archive
Key Words
effective regurgitant orifice
isolated tricuspid regurgitation
prognosis
tricuspid regurgitation
Abbreviations and Acronyms
ERO
effective regurgitant orifice
RV
right ventricular
SPAP
systolic pulmonary artery pressure
TR
tricuspid regurgitation
Cited by (0)
Dr. Suri is a national principal investigator for the Sorin-Perceval Trial 2; is the co-principal investigator for the Abbott COAPT trial 3 and COAPT trial; is a Clinical Steering Committee of the St. Jude Medical Portico Trial; has patent applications with Sorin Perceval Trial and Sorin; and has received research support from Sorin, Abbott, St. Jude Medical, and Edwards Lifesciences. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.